Recently, it has been shown that that miR-124-3p attenuated tumor metastasis by inhibiting PDCD6 expression, and that the miR-124-3p/PDCD6 signaling axis could potentially be a therapeutic target for patients with advanced breast cancer [43]. This evidence concerns the gene PDCD6 and breast cancer.